| Product Name | MF | CAS | Details |
|---|
| 5.88.3 | Details |
| 55E7-79 | Details |
| 4D12 [Mouse/rat hybridoma against mouse Klra3/Klra5] | Details |
| 559/64-D100,10,1 | Details |
| 58B2C | Details |
| 4E12 [Mouse hybridoma against human IL2] | Details |
| 4Z-B-1 | Details |
| 529SU | Details |
| 58CrPM | Details |
| 52 | C15H23NO2 | Details |
| 53-7.313 | Details |
| 4B4-1-1 | Details |
| 4nFC | Details |
| 4E10-1.14 | Details |
| 52M51 | Details |
| 4G10 [Mouse hybridoma against T.mossambica IgM] | Details |
| 5637 subclone 1A6 | Details |
| 54B3 | Details |
| 4D1 [Mouse hybridoma against SYNV P] | Details |
| 4C1 [Mouse hybridoma against P.falciparum csp] | Details |
| 4NfinP9 | Details |
| 4MBr-5 | Details |
| 4G6F3 | Details |
| 517F1 | Details |
| 558-D100,10,1 | Details |
| 4E7 | Details |
| 53B3 | Details |
| 4G4 [Mouse hybridoma against marinobufagenin] | Details |
| 4D20.8 | Details |
| 53-S | Details |
| 50 AZA SEL | Details |
| 4C7.2.1 | Details |
| 4C8B9 | Details |
| 528 [Mouse hybridoma against human EGFR] | Details |
| 4E8C12 | Details |
| 4D8 [Mouse hybridoma against human FOLH1] | Details |
| 4G12-13 | Details |
| 5637 | Details |
| 534G9 | Details |
| 4C | Details |
| 501.1 | Details |
| 53-569 | Details |
| 4G12 [Mouse hybridoma against ASFV CD2v] | Details |
| 53-6.72 | Details |
| 5637rCDDP1000 | Details |
| 547A1 | Details |
| 4B2-6C3-1C9 | Details |
| 4E12B2D10 | Details |
| 4D1.5.7 | Details |
| 5-5-6 | Details |
| 5/9 m a3-18 | Details |
| 4G1-D2 | Details |
| 4H7 [Mouse hybridoma against BPV12 VP7] | Details |
| 56B3 | Details |
| 4F8 [Mouse hybridoma against influenza A virus HA] | Details |
| 4H2 [Mouse hybridoma against marinobufagenin] | Details |
| 4D4 [Mouse hybridoma against human FOLH1] | Details |
| 4BA7 | Details |
| 4B7 [Mouse hybridoma against P.falciparum pfs25] | Details |
| 4E7.24.3 | Details |
| 50-6 | Details |
| 4C2 | Details |
| 530C8 | Details |
| 4C4.1 | Details |
| 4F10 [Human EBV-transformed] | Details |
| 535F7 | Details |
| 4T1-Par3 | Details |
| 4H6.17.8 | Details |
| 4f1-1 | Details |
| 533 OOS | Details |
| 4F7 [Mouse hybridoma against P.vivax RBP2b] | Details |
| 520C9 | Details |
| 4D3 [Mouse hybridoma against cell wall peptidoglycans] | Details |
| 4C6 [Mouse hybridoma against P.falciparum csp] | Details |
| 575A | Details |
| 4C1 [Mouse hybridoma against A.australis AaH2] | Details |
| 4F6 [Mouse hybridoma against human TACSTD2] | Details |
| 4D1 [Mouse hybridoma against human GRN] | Details |
| 58D3C9 | Details |
| 579 | Details |
| 4F10 [Mouse USA hybridoma against human GRN] | Details |
| 4D1 [Mouse hybridoma against influenza A virus HA] | Details |
| 5637rGEMCI20 | Details |
| 4H7H7 | Details |
| 4F1B5 | Details |
| 4G10 [Mouse hybridoma against ginsenoside Re] | Details |
| 5-21-3 | Details |
| 4C3 [Mouse hybridoma against human MSMB] | Details |
| 52-S | Details |
| 4G11 1.C12 | Details |
| 4F4 | Details |
| 4B3A4 | Details |
| 4T1-Dura3 | Details |
| 4B2-E2-E7-C3 | Details |
| 4G7.18.8 | Details |
| 4F2 [Mouse hybridoma against fenitrothion] | Details |
| 4B9 [Human LCL mAb producing] | Details |
| 4E12B2 | Details |
| 4G7 | Details |
| 4E11 [Mouse hybridoma against FLAG peptide] | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 | ||||